awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42316098-5209287E-D70E-4146-BA46-46EA728CED76
Q42316098-5209287E-D70E-4146-BA46-46EA728CED76
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42316098-5209287E-D70E-4146-BA46-46EA728CED76
miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway
P2860
Q42316098-5209287E-D70E-4146-BA46-46EA728CED76
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42316098-5209287E-D70E-4146-BA46-46EA728CED76
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be5053c6c174d8ec8126ec0529b481f19e87a135
P2860
A phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer.